MeSH term
Frequency | Condition_Probility | Humans | 14 | 0.0 |
*Intracellular Signaling Peptides and Proteins | 11 | 1.0 |
Precipitin Tests | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Two-Hybrid System Techniques | 3 | 0.0 |
Carrier Proteins/*metabolism | 4 | 0.0 |
Cell Line | 5 | 0.0 |
*Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Proto-Oncogene Proteins c-myc/*metabolism | 6 | 6.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 3 | 0.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Jurkat Cells | 2 | 0.0 |
Protein Binding | 4 | 0.0 |
Leucine Zippers | 2 | 1.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Cytoplasm/*metabolism | 2 | 1.0 |
Amino Acid Sequence | 3 | 0.0 |
Cells, Cultured | 3 | 0.0 |
Interferon Inducers/*metabolism | 2 | 100.0 |
Molecular Sequence Data | 3 | 0.0 |
*Protein Structure, Tertiary | 2 | 1.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Subcellular Fractions/*metabolism | 2 | 10.0 |
Interferon-alpha/*pharmacology | 2 | 1.0 |
Comparative Study | 2 | 0.0 |
Cell Line, Tumor | 2 | 0.0 |
